|
Suing for Mesothelioma
Asbestos litigation has yielded the highest payouts and legal costs over the longest period of time of any litigation in U.S. history.
A popular study published by the Rand Corporation in 2004 discovered that as of 2002, 730,000 plaintiffs had sued 8,400 defendants for asbestos-related illnesses.
The total cost for asbestos litigation as of 2002 was upwards $70 billion with an estimated total cost going forward of $250 billion. Approximately 100,000 lawsuits are filed yearly for asbestos-related illnesses.
85 corporations filed for bankruptcy as of 2002 due to asbestos lawsuits. One reason asbestos lawsuits have such a high success rate is because Mesothelioma and other asbestos-related cancers can only occur from exposure to airborne asbestos fibers.
Therefore, having an asbestos-related illness is often proof positive of asbestos exposure. Attorneys then need only prove, as required by law, whether the defendant failed in his or her legal duty to protect the plaintiff from asbestos exposure.
Asbestos and Lung Cancer
Asbestos is a fibrous organic material found in metamorphic rock. It was frequently used in thousands of products in the mid-twentieth century. Asbestos fibers settle in the cellular lining of the lungs causing lung cancer over time. Airborne asbestos fibers are microscopic and virtually invisible to the naked eye.
En masse and over a period of 30 to 40 years, accumulated asbestos fibers can lead to lung-related illnesses, such as pleural mesothelioma, lung cancer and asbestosis. Federal and state laws provide monetary damages for those with asbestos-related injuries.
Keywords: Keywords: contingency fee agreement, contingency fee mesothelioma, contingency fee asbestos, mesothelioma attorneys, mesothelioma lawyers, hiring mesothelioma lawyer, asbestos litigation, asbestos exposure, mesothelioma lawsuit, asbestos attorney, asbestos lawyer, mesothelioma cancer, mesothelioma asbestos, statute of limitations asbestos, statute limitations mesothelioma, mesothelioma personal injury |
